Statement of Financial Position (USD $)	Dec. 31, 2014	Mar. 31, 2014
Assets, Current
Cash and Cash Equivalents, at Carrying Value	$ 613,608	$ 1,873,141
Prepayments and Other Assets	39,724us-gaap_PrepaidExpenseAndOtherAssets	20,390us-gaap_PrepaidExpenseAndOtherAssets
Prepayment to Related Party for clinical trials	465,454us-gaap_PrepaidExpenseCurrent
Assets, Current	1,118,786us-gaap_AssetsCurrent	1,893,531us-gaap_AssetsCurrent
Assets, Noncurrent
Finite-Lived Intangible Assets, Net	115,863us-gaap_FiniteLivedIntangibleAssetsNet	70,781us-gaap_FiniteLivedIntangibleAssetsNet
Restricted Cash, Noncurrent		85,462
Tangible Fixed Assets	6,154us-gaap_OtherAssetsNoncurrent
Assets, Noncurrent	122,017us-gaap_AssetsNoncurrent	156,243us-gaap_AssetsNoncurrent
Assets	1,240,803us-gaap_Assets	2,049,774us-gaap_Assets
Liabilities, Current
Accounts Payable, Current	50,408us-gaap_AccountsPayableCurrent	1,830us-gaap_AccountsPayableCurrent
Other Liabilities, Current	4,362us-gaap_OtherLiabilitiesCurrent	6,844us-gaap_OtherLiabilitiesCurrent
Liabilities, Current	54,770us-gaap_LiabilitiesCurrent	8,674us-gaap_LiabilitiesCurrent
Liabilities, Noncurrent
Deferred Revenue and Credits, Noncurrent	1,566,600	1,667,200
Liabilities, Noncurrent	1,566,600us-gaap_LiabilitiesNoncurrent	1,667,200us-gaap_LiabilitiesNoncurrent
Liabilities	1,621,370us-gaap_Liabilities	1,675,874us-gaap_Liabilities
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Common Stock, Value, Issued	200,000us-gaap_CommonStockValue	200,000us-gaap_CommonStockValue
Additional Paid in Capital, Common Stock	2,924,672	2,924,672
Accumulated Other Comprehensive Income (Loss), Net of Tax	20,552	(8,882)
Retained Earnings (Accumulated Deficit)	(3,525,791)	(2,741,890)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	(380,567)	373,900
Liabilities and Equity	$ 1,240,803	$ 2,049,774

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682